PTGS2 and colorectal adenocarcinoma: The authors confirmed the specificity of compound 5 for COX-2 with cellular uptake studies (especially in the COX-2+ human colorectal adenocarcinoma cell line HT-29 vs. COX-2- RAW264.7).